Johnson & Johnson
Johnson & Johnson is an American multinational healthcare corporation that develops and manufactures pharmaceuticals and medical devices. The company operates through two primary business segments: Innovative Medicine, which focuses on prescription drugs in oncology, immunology, and neuroscience, and MedTech, which provides surgical equipment, orthopedic solutions, and cardiovascular products. Its principal revenue drivers are global sales of proprietary pharmaceuticals and specialized medical technologies to hospitals, healthcare providers, and distributors worldwide. As one of the largest healthcare entities in the world, the enterprise holds a dominant market position across multiple therapeutic categories and medical device sectors. Headquartered in New Brunswick, New Jersey, Johnson & Johnson is publicly traded on the New York Stock Exchange under the ticker symbol JNJ.
176 of the funds FundTelligence covers report a position in Johnson & Johnson.
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 176
Funds holding Johnson & Johnson
- Polar Capital Global Healthcare Select Fund — Polar Capital · 9.4 % (largest positions only, October 2026)
- Schroder ISF Hlthcr Innovt — Schroders · 9.39 % (largest positions only, September 2026)
- AB International Health Care Portfolio — AllianceBernstein · 9.27 % (largest positions only, September 2026)
- Schroder ISF Healthcare Innovation — Schroders · 9.21 % (full portfolio disclosed, June 2026)
- Handelsbanken Helse Tema — Handelsbanken · 8.9 % (full portfolio disclosed, October 2026)
- GS Global Future Health Care Equity Portfolio — Goldman Sachs · 8.86 % (largest positions only, September 2026)
- BGF World Healthscience Fund — BlackRock · 8.63 % (largest positions only, October 2026)
- Fidelity Global Healthcare Fund — Fidelity · 7.7 % (largest positions only, October 2026)
Showing the 8 largest of 176 funds holding it.